These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


381 related items for PubMed ID: 6304866

  • 1. Myeloperoxidase-deficient polymorphonuclear leucocytes. (I) Incidence in untreated myeloid leukaemia, lymphoid leukaemia and normal humans.
    Bendix-Hansen K, Kaspersen Nielsen H.
    Scand J Haematol; 1983 May; 30(5):415-9. PubMed ID: 6304866
    [Abstract] [Full Text] [Related]

  • 2. Myeloperoxidase deficient polymorphonuclear leucocytes in leukaemia and allied disorders.
    Bendix-Hansen K.
    Dan Med Bull; 1988 Dec; 35(6):501-20. PubMed ID: 2851415
    [Abstract] [Full Text] [Related]

  • 3. Myeloperoxidase-deficient polymorphonuclear leucocytes. (II) Longitudinal study in acute myeloid leukaemia, untreated, in remission and in relapse.
    Bendix-Hansen K, Nielsen HK.
    Scand J Haematol; 1983 Jul; 31(1):5-8. PubMed ID: 6306759
    [Abstract] [Full Text] [Related]

  • 4. Myeloperoxidase-deficient polymorphonuclear leucocytes (III): Relation to incidence of infection in acute myeloid leukaemia.
    Nielsen HK, Bendix-Hansen K.
    Scand J Haematol; 1984 Jul; 33(1):75-9. PubMed ID: 6087443
    [Abstract] [Full Text] [Related]

  • 5. Myeloperoxidase-deficient polymorphonuclear leucocytes. (IV): Relation to FAB-classification in acute myeloid leukaemia.
    Bendix-Hansen K, Nielsen HK.
    Scand J Haematol; 1985 Aug; 35(2):174-7. PubMed ID: 2996122
    [Abstract] [Full Text] [Related]

  • 6. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
    Anand M, Ghara N, Kumar R, Singh S, Sengar M, Panikar N, Raina V, Sharma A.
    Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
    [Abstract] [Full Text] [Related]

  • 7. Myeloperoxidase-deficient polymorphonuclear leucocytes (VII): Incidence in untreated myeloproliferative disorders.
    Bendix-Hansen K.
    Scand J Haematol; 1986 Jan; 36(1):8-10. PubMed ID: 3006224
    [Abstract] [Full Text] [Related]

  • 8. Myeloperoxidase-deficient polymorphonuclear leucocytes. Longitudinal study during the preremission--and the remission phase in acute myeloid leukaemia. Comparison to neutrophil alkaline phosphatase (NAP) activity.
    Bendix-Hansen K.
    Blut; 1986 Apr; 52(4):237-42. PubMed ID: 3008894
    [Abstract] [Full Text] [Related]

  • 9. Myeloperoxidase deficient polymorphonuclear leucocytes: computerized planimetric estimations of cellular and nuclear size.
    Bendix-Hansen K.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986 Apr; 52(4):319-25. PubMed ID: 2883756
    [Abstract] [Full Text] [Related]

  • 10. Abnormal pattern of bactericidal activity of neutrophils deficient in granules, myeloperoxidase, and alkaline phosphatase.
    Repine JE, Clawson CC, Brunning RD.
    J Lab Clin Med; 1976 Nov; 88(5):788-95. PubMed ID: 185307
    [Abstract] [Full Text] [Related]

  • 11. Neutrophil myeloperoxidase: a simple, reproducible technique to determine activity.
    Kitahara M, Simonian Y, Eyre HJ.
    J Lab Clin Med; 1979 Feb; 93(2):232-7. PubMed ID: 219116
    [Abstract] [Full Text] [Related]

  • 12. Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient.
    Stendahl O, Coble BI, Dahlgren C, Hed J, Molin L.
    J Clin Invest; 1984 Feb; 73(2):366-73. PubMed ID: 6321554
    [Abstract] [Full Text] [Related]

  • 13. Partial myeloperoxidase deficiency in a case of preleukaemia. II. Defects of degranulation and abnormal bactericidal activity of blood neutrophils.
    Breton-Gorius J, Houssay D, Vilde JL, Dreyfus B.
    Br J Haematol; 1975 Jul; 30(3):279-88. PubMed ID: 172112
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Distinct alpha-L-fucosidase isoenzyme profiles in human leukemic cells.
    Orlacchio A, Emiliani C, Rambotti P, Pioda GB, Davis S.
    Anticancer Res; 1988 Jul; 8(1):165-8. PubMed ID: 3162792
    [Abstract] [Full Text] [Related]

  • 18. Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency.
    Nauseef WM, Root RK, Malech HL.
    J Clin Invest; 1983 May; 71(5):1297-307. PubMed ID: 6189859
    [Abstract] [Full Text] [Related]

  • 19. Comparison of myeloperoxidase detection by flow cytometry using two different clones of monoclonal antibodies.
    Leong CF, Kalaichelvi AV, Cheong SK, Hamidah NH, Rahman J, Sivagengei K.
    Malays J Pathol; 2004 Dec; 26(2):111-6. PubMed ID: 16329563
    [Abstract] [Full Text] [Related]

  • 20. Acquired neutrophil myeloperoxidase deficiency: an indicator of subclinical activation of blood coagulation?
    d'Onofrio G, Mancini R, Vallone R, Alfano G, Candido A, Palla M, Mango G.
    Blood Cells; 1983 Dec; 9(3):455-66. PubMed ID: 6326898
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.